Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Revenue (2023 - 2026)

BioScience Health Innovations has reported Revenue over the past 4 years, most recently at $750946.0 for Q1 2026.

  • Quarterly Revenue fell 38.8% to $750946.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Mar 2026, up 86.53% year-over-year, with the annual reading at $5.7 million for FY2025, 208.34% up from the prior year.
  • Revenue was $750946.0 for Q1 2026 at BioScience Health Innovations, down from $1.6 million in the prior quarter.
  • Over five years, Revenue peaked at $1.8 million in Q2 2025 and troughed at $32337.0 in Q1 2023.
  • The 4-year median for Revenue is $572973.0 (2024), against an average of $683248.0.
  • Year-over-year, Revenue soared 758.46% in 2024 and then crashed 38.8% in 2026.
  • A 4-year view of Revenue shows it stood at $303628.0 in 2023, then soared by 100.98% to $610222.0 in 2024, then surged by 157.74% to $1.6 million in 2025, then plummeted by 52.25% to $750946.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Revenue are $750946.0 (Q1 2026), $1.6 million (Q4 2025), and $1.1 million (Q3 2025).